Krystal Biotech (KRYS) continues to face heavy short-selling pressure, remaining on the FINRA threshold list for 77 consecutive trading days. The company currently reports a short interest of 13.7% of the float. With a days-to-cover ratio of 10.3, the stock is susceptible to increased volatility should short sellers be forced to cover their positions. The borrow fee is currently reported at 0.3%. The combination of high short interest and a significant days-to-cover metric makes KRYS a ticker to watch for potential squeeze setups, provided there is a catalyst for a price reversal.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.